Karl Tobieson

Filings by Karl Tobieson span 2 companies, the busiest being Linc AB and MedCap AB (publ). The record holds 24 filings, for trades running from 28 May 2021 to 23 October 2026.

Both buying and selling appear: 18 purchases worth €12.2M, against 4 sales worth €1.1M. The net balance comes to €11.1M on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 6 purchases and no sales.

The median purchase comes to €63k. Relative to company size, the median is 0.017% of market cap (11 purchases with a known value). 2 out of 17 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 14 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 57% of cases, with a median move of +1.0%. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 23 October 2026 with an open-market purchase (€63k) in Linc AB. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.